These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28035756)

  • 1. Response to the letter to the editor Reply to Restolho et al. "Contactless decontamination of hair samples: cannabinoids" by Moosmann and Auwärter.
    Restolho J; Barroso M; Saramago B; Dias M; Afonso CA
    Drug Test Anal; 2017 Feb; 9(2):290-292. PubMed ID: 28035756
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Restolho et al. 'Contactless decontamination of hair samples: cannabinoids'.
    Moosmann B; Auwärter V
    Drug Test Anal; 2017 Feb; 9(2):289-290. PubMed ID: 27783890
    [No Abstract]   [Full Text] [Related]  

  • 3. Contactless decontamination of hair samples: cannabinoids.
    Restolho J; Barroso M; Saramago B; Dias M; Afonso CA
    Drug Test Anal; 2017 Feb; 9(2):282-288. PubMed ID: 27074965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Companies should test the limits of their decontamination procedures--Reply to: Comments on "Ethnic hair care products may increase false positive in hair" V. Hill et al.
    Kidwell DA; Smith FP
    Forensic Sci Int; 2016 Feb; 259():e51. PubMed ID: 26672400
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: letter to the editor in response to Morton et al. (2007) Carcinogenesis, 28, 1759-1764.
    Bailey JE; Skare JA
    Carcinogenesis; 2008 Sep; 29(9):1851. PubMed ID: 18218828
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation between consumption and external contamination when testing for cocaine and cannabis in hair samples.
    Tsanaclis L; Nutt J; Bagley K; Bevan S; Wicks J
    Drug Test Anal; 2014 Jun; 6 Suppl 1():37-41. PubMed ID: 24817047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence based decontamination protocols for the removal of external Δ9-tetrahydrocannabinol (THC) from contaminated hair.
    Duvivier WF; Peeters RJ; van Beek TA; Nielen MW
    Forensic Sci Int; 2016 Feb; 259():110-8. PubMed ID: 26773221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to "Letter to Editor, in response to Narain et al.".
    Singh K
    Spine J; 2017 Nov; 17(11):1767. PubMed ID: 29150263
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on "morphological changes in human head hair subjected to various drug testing decontamination strategies" by Stout et al.
    Hill V; Schaffer M; Cairns T
    Forensic Sci Int; 2008 Jul; 178(2-3):e47-8; author reply e49-52. PubMed ID: 18424025
    [No Abstract]   [Full Text] [Related]  

  • 10. In reply to letter to the editor by Dr Willems et al. re: Eccles et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations.
    Eccles C; Haider MA; Dawson LA
    Acta Oncol; 2010; 49(2):256-7. PubMed ID: 20017663
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Letter to the Editor regarding article by Miranda et al.
    Morrison SD; Liu Y; Said HK
    J Plast Reconstr Aesthet Surg; 2017 Mar; 70(3):427-428. PubMed ID: 28089861
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to the Letter to the Editor by Sollini M et al.
    Pacini F; Elisei R; Fugazzola L; Ferdeghini M; Mariotti S; Pellegriti G
    J Endocrinol Invest; 2016 Apr; 39(4):487-8. PubMed ID: 26940215
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Letter to the Editor by Crocoli A, et al.
    Kaji T
    J Pediatr Surg; 2017 Sep; 52(9):1537. PubMed ID: 28648879
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to the Letter to the Editor by Mueller et al.
    Pascale A; Beal M
    Womens Health Issues; 2016; 26(4):478. PubMed ID: 27448752
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to the letter to editor by Gaye et al.
    Manczuk M; Vaidean G
    Int J Cardiol; 2017 Jul; 239():31-32. PubMed ID: 28560977
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to letter to the editor titled "a questionable conclusion by Ido Stahl et al.".
    Stahl I; Haddad E; Hous N; Dreyfuss D
    Spine J; 2017 Jul; 17(7):1058-1059. PubMed ID: 28625803
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Letter to the Editor by R.L. Jump et al.
    Zarowitz BJ; Allen C; Tangalos E; Ouslander JG
    J Am Med Dir Assoc; 2016 Aug; 17(8):755. PubMed ID: 27378273
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to the Letter to the Editor by Mori et al.
    Nishiguchi S; Yamada M; Shirooka H; Nozaki Y; Fukutani N; Tashiro Y; Hirata H; Yamaguchi M; Tasaka S; Matsushita T; Matsubara K; Tsuboyama T; Aoyama T
    J Am Med Dir Assoc; 2016 Jun; 17(6):560-1. PubMed ID: 27143235
    [No Abstract]   [Full Text] [Related]  

  • 19. Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".
    Durrani K; Kempen JH; Foster CS;
    Ocul Immunol Inflamm; 2019; 27(1):71. PubMed ID: 29043914
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to the letter to the editor by Guinn et al.
    Karban J; Mocikova H; Pytlik R; Klener P; Trneny M
    Eur J Haematol; 2011 Nov; 87(5):470. PubMed ID: 21883479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.